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Relative and absolute quantiﬁcation of proteins in biological and clinical samples are
common approaches in proteomics. Until now, targeted protein quantiﬁcation is mainly
performed using a combination of HPLC-based peptide separation and selected reaction
monitoring on triple quadrupole mass spectrometers. Here, we show for the ﬁrst time the
potential of absolute quantiﬁcation using a direct infusion strategy combined with single
ion monitoring (SIM) on a Q Exactive mass spectrometer. By using complex membrane frac-
tions  of Escherichia coli,  we absolutely quantiﬁed the recombinant expressed heterologous
human cytochrome P450 monooxygenase 3A4 (CYP3A4) comparing direct infusion-SIM with
conventional HPLC-SIM. Direct-infusion SIM revealed only 14.7% (±4.1 (s.e.m.)) deviation on
average, compared to HPLC-SIM and a decreased processing and analysis time of 4.5 min
(that could be further decreased to 30 s) for a single sample in contrast to 65 min  by theQ Exactive
Cytochrome P450 (CYP)
LC–MS method. Summarized, our simpliﬁed workﬂow using direct infusion-SIM provides a
fast  and robust method for quantiﬁcation of proteins in complex protein mixtures.
©  2015 The Authors. Published by Elsevier B.V. on behalf of European Proteomics
Association (EuPA). This is an open access article under the CC BY-NC-ND license
energy optimization. Utilizing the Q Exactive mass spectrom-1.  Introduction
Quantiﬁcation of proteins is a common approach in pro-
teomics. Using heavy isotope labeled peptides, absolute
quantiﬁcation of speciﬁc proteins by selected reaction mon-
itoring (SRM), a targeted mass spectrometric approach
measured on a triple quadrupole mass spectrometer, is a well-
established method [1–6]. Although SRM measurements are
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article  under the CC BY-NC-ND license (http://creativecommons.org/lic(http://creativecommons.org/licenses/by-nc-nd/4.0/).
sensitive and highly selective, a triple quadrupole does not
show high resolution and high mass accuracy. Furthermore,
absolute quantiﬁcation with SRM requires method optimiza-
tion for every new protein of interest or peptides representing
the protein with regard to selection of transitions and collisioneter (Thermo Scientiﬁc), which combines a quadrupole mass
ﬁlter and an orbitrap mass analyzer, targeted approaches can
be carried out with high resolution and accurate mass (HR/AM)
 European Proteomics Association (EuPA). This is an open access
enses/by-nc-nd/4.0/).
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etection [7]. Furthermore, quantiﬁcation can be performed
y single ion monitoring (SIM) at MS  level or parallel reaction
onitoring (PRM) at MS/MS  level [8,9]. In the SIM mode, the
uadrupole isolates the precursor mass of interest in a narrow
indow of e.g. 2 m/z. Then, ions are accumulated in the C-Trap
nd analyzed in the orbitrap. In a standard proteomics work-
ow prior to mass spectrometry (MS) measurement an HPLC is
sed for pre-fractionation of the peptide mixture, which usu-
lly takes about 1–2 h depending on sample complexity. So far,
he direct infusion MS  setup is applied for characterization
nd quantiﬁcation of metabolites, for example in lipid proﬁl-
ng to investigate the progression of colorectal cancer [10] or
o detect metabolite changes in liver extracts from mice after
xposure to polychlorinated biphenyls [11]. To our knowledge
 direct infusion-SIM approach has not been used to abso-
utely quantify proteins from complex biological samples until
ow. This method might be of special interest e.g. for protein
uantiﬁcation in biotechnological systems, such as whole-cell
iocatalysts as well as other biological systems like cells or tis-
ues. In order to establish an efﬁcient biocatalyst and process
etup, a fast and reliable absolute quantiﬁcation of the target
rotein from the biological matrix is important to deﬁne or
onitor optimal reaction conditions to achieve high amounts
f active protein. Here, we  applied the direct infusion-SIM
pproach to quantify the heterologously expressed human
ytochrome P450 monooxygenase 3A4 (CYP3A4), which was
roduced in Escherichia coli. Human cytochrome P450 enzymes
re a family of membrane-bound heme-containing monooxy-
enases responsible for the metabolism of many  endogenous
ompounds as well as xenobiotics, mainly in the liver [12,13].
he enzymes are of special interest as biocatalysts in order
o synthesize gram-scale amounts of drug metabolites [14].
he overall aim of this study was to develop a fast, robust
nd reproducible method for protein quantiﬁcation that can
e used to (absolutely) quantify proteins from complex pro-
ein mixtures, e.g. E. coli membrane fractions. We performed
irect infusion-SIM with the Q Exactive mass spectrometer
nd compared results to data obtained with a conventional
PLC-SIM approach. Direct infusion-SIM appeared to be a fast
nd accurate tool for the determination of absolute abundance
f proteins in complex biological samples.
.  Experimental  procedures
.1.  Reagents
3C6/15N2-Lys labeled peptides were purchased from Thermo.
olvents used for mass spectrometry were all HPLC/MS
rade. Acetonitrile (ACN) was purchased from Biosolve, triﬂu-
roacetic acid (TFA) and formic acid (FA) from Sigma Aldrich.
.2.  E.  coli  cultivation  and  CYP3A4  synthesis
. coli DH5 [15] containing the genes encoding human CYP3A4
nd cytochrome P450 reductase on the plasmid pCW3A4
16] was used. E. coli DH5 (pCWori(+)) was used as con-
rol strain without CYP3A4. A single colony of E. coli DH5
rom an LB agar plate [17] was used to inoculate 3 ml  LB
edium, which were grown overnight at 37 ◦C and 200 rpm 7 ( 2 0 1 5 ) 20–26 21
to a biomass concentration of about 1 gCDW l−1. The precul-
tures were diluted to a biomass concentration of 33 mgCDW l−1
in 40 or 100 ml  TB medium (0.89 M KPO4 buffer (potassium
phosphate buffer), pH 7.4, 24 g l−1 yeast extract, 12 g l−1 tryp-
tone, 2 g l−1 peptone, 4 ml  l−1 glycerol, 1 mM thiamin, 25 l l−1
trace elements and 100 mg  l−1 ampicillin) [18] in non-bafﬂed,
capped 250 ml  Erlenmeyer ﬂasks. The cultures were incu-
bated at 30 ◦C and 200 rpm (rotary incubator) until a biomass
concentration of 83 mgCDW l−1 was obtained. Then, gene
expression was induced by the addition of 1 mM IPTG, 0.5 mM
-aminolevulinic acid (-ALA), and 25 M FeCl3 and incuba-
tion was continued for another 24 h. Cells were harvested
by centrifugation (20 min  at 4700 × g and 4 ◦C) and resus-
pended in 100 mM KPO4 (pH 7.4) containing 20% glycerol,
1 mM EDTA, 0.1 mM dithiothreitol (DTT), and 0.2 mM Pefabloc
(Sigma–Aldrich) at 17 gCDW l−1 and stored at −20 ◦C until usage.
2.3.  Membrane  isolation
Cell lysis was achieved by two passages through a French
Press, followed by centrifugation (20 min, 4 ◦C, 4700 × g) and
ultracentrifugation of the supernatant (2 h, 4 ◦C, 40,800 × g).
Membranes were resuspended in 100 mM KPO4 buffer (pH 7.4)
containing 20% glycerol, 1 mM EDTA and 0.1 mM dithiothreitol
(DTT) and stored at −20 ◦C.
2.4.  Sample  preparation
Membrane fractions containing human CYP3A4 were sub-
jected to tryptic digestion. For each tryptic digest 10 g protein
were used and 110 fmol l−1 of each heavy peptide were
spiked. Samples were reduced for 20 min  at 56 ◦C with 5 mM
DTT and alkylated with 15 mM iodoacetamide in the dark for
15 min. Digestion was carried out over night at 37 ◦C with
trypsin (trypsin:protein ratio 1:5.5) in the presence of 0.01%
(wt/vol) ProteaseMAX (Promega), 15 mM bicine and 30 mM
NH4HCO3. After stopping the digestion by addition of 0.5%
TFA, samples were puriﬁed using OMIX columns (Agilent
Technologies) and eluted in water containing 55% ACN and
0.1% TFA. Eluates were concentrated in a vacuum concentrator
and resolved in 100 l water containing 40% ACN/0.1% FA.
2.5.  Direct  infusion-SIM  with  HESI  source
Samples were loaded in a 250 l Hamilton syringe, injected
by a syringe pump with a ﬂow rate of 5 l min−1 into the
HESI (heated electrospray ionization) source and measured
for 4.5 min  with a SIM method on a Q Exactive Hybrid
Quadrupole-Orbitrap mass spectrometer (Thermo Scientiﬁc).
For ionization a spray voltage of 3.6 kV and capillary temper-
ature of 320 ◦C was used and sheath gas ﬂow rate was set to
6 units. The acquisition method consisted of two  scan events,
Full MS and targeted SIM (t-SIM). The Full MS  was monitored
from m/z 350–1400, with an orbitrap resolution of 35,000 (at m/z
200), a maximum injection time of 120 ms  and an automatic
gain control (AGC) value of 3e6. The t-SIM was performed with
a resolution of 70,000 (at m/z 200), a maximum injection time
of 250 ms  and an automatic gain control (AGC) value of 1e5.
o m i c22  e u  p a o p e n p r o t e 
The isolation window was 2 m/z for the respective masses of
light and heavy peptides.
2.6.  Direct  infusion-MS/MS  with  HESI  source
Samples were injected into the mass spectrometer and ion-
ized as described above. In order to manually acquire MS/MS
spectra of the respective peptides, the following scan param-
eters were set in the Tune software (Thermo Scientiﬁc). The
scan type was Full MS-SIM and in the scan range the center
m/z  was set to the m/z of interest with an isolation window
of 2 m/z. The isolated m/z  was fragmented with a normalized
collision energy of 27 in the HCD (higher-energy collisional
induced dissociation) cell and fragment spectra were moni-
tored from m/z  150–1300, with an orbitrap resolution of 70,000
(at m/z 200).
2.7.  Direct  infusion-SIM  with  nano  source
For direct infusion with the nano source the Ofﬂine Nano ES
kit (Thermo Scientiﬁc) was used. Samples were loaded in a
Borosilicate Ofﬂine Emitter (Thermo Scientiﬁc), injected by
means of the static air pressure device and measured for
4.5 min  with a SIM method on a Q Exactive Hybrid Quadrupole-
Orbitrap mass spectrometer (Thermo Scientiﬁc). For ioniza-
tion a spray voltage of 1.5 kV and capillary temperature of
250 ◦C was used. Subsequently, measurement was performed
as described in direct infusion-SIM with HESI source.
2.8.  HPLC-SIM
Samples were diluted 1:15 in 0.1% TFA. 15 l were injected
via the autosampler of an RSLC nano system (Thermo Sci-
entiﬁc), concentrated on a C18 trapping column (2 cm length,
100 m i.d., 5 m particle size, Thermo Scientiﬁc), and sep-
arated on a C18 analytical column (50 cm length, 75 m i.d.,
2 m particle size, Thermo Scientiﬁc) heated at 60 ◦C before
being emitted via a coated silica tip (FS360-20-10-D-20, New
Objective) of the nano-electrospray source. The HPLC separa-
tion was performed with a gradient method of in total 65 min
gradient consisting of: 6 min  of loading the sample and wash-
ing the column with 0.1% TFA at a ﬂow rate of 30 l min−1 on
the trapping column, followed by separation applying a lin-
ear gradient at a ﬂow rate of 400 nl min−1 with the solvents
A (0.1% FA in HPLC grade water) and B (84% ACN/0.1% FA in
HPLC grade water) starting from 4% B to 40% B in 34 min  on the
heated analytical column, a linear gradient of 40% B to 95% B
in 3 min, washing for 5 min  with 95% B. Finally, a gradient was
applied from 95% B to 4% B in 1 min  followed by equilibration
for 16 min  with 4% B. For ionization a spray voltage of 1.6 kV
and capillary temperature of 250 ◦C was used. The acquisi-
tion method was the same as described above in the direct
infusion-SIM with HESI source section. The t-SIM scans were
time scheduled and multiplexed: m/z values of the respec-
tive light and heavy CYP3A4 peptides were scanned only in a
speciﬁc time window and the ions were isolated sequentially,
stored together in the C-Trap and detected in the orbitrap in
one single scan. s 7 ( 2 0 1 5 ) 20–26
2.9.  Data  evaluation
Data evaluation was performed with the XCalibur software
(Thermo Scientiﬁc) and Microsoft Excel (Microsoft Corpora-
tion). After direct infusion-SIM, raw ﬁles were loaded in the
XCalibur Qual Browser, the plot type was set to base peak (as
with the base peak chromatogram the noise level is decreased
compared to the total ion chromatogram) and the scan ﬁl-
ter was set to the respective masses. Then the intensity of
this mass was averaged over the whole measurement time
and the intensity of the monoisotopic peak was transferred in
Excel. For comparison, intensities of respective masses were
averaged over 30 s (minute 1.5–minute 2.0) and the intensi-
ties of the monoisotopic peaks were transferred in Excel. After
HPLC-SIM, raw ﬁles were also loaded in the XCalibur Qual
Browser and the scan ﬁlter was set to the respective multi-
plexed masses. Then, the intensities were averaged over the
elution proﬁle, which borders were set manually with the
same elution span for each peptide and the intensity of each
monoisotopic peak was again transferred in Excel. The ratios
of light/heavy CYP3A4 peptide were calculated and a linear
curve was established by plotting the ratios of the intensi-
ties of light/heavy peptide against the amounts of spiked light
peptide. The linear equation and regression coefﬁcient were
calculated for each peptide (supporting information Fig. S-1a
and b). Using the respective linear equation, the amounts of
expressed CYP3A4 were calculated.
3.  Results  and  discussion
3.1.  Selection  of  appropriate  peptides  for  direct
infusion-SIM
Peptides that are used for quantiﬁcation need to be chosen
carefully and should meet the following criteria: (1) they need
to be proteotypic for the quantiﬁed protein, (2) they should
not contain post-translational modiﬁcations, (3) they should
contain neither methionine nor cysteine, which tend to be
chemically modiﬁed, and (4) they should not show any miscle-
avages [19]. Furthermore, for direct infusion approaches it is
important that peptide masses are unique. According to this
two tryptic CYP3A4 peptides (LQEEIDAVLPNK, m/z 684.8721;
YWTEPEK, m/z 476.7242) met  the described speciﬁcations and
were selected for the setup of a direct infusion-SIM method
using the Q Exactive. We  set the instrument to SIM scan mode
with the respective monoisotopic masses (m/z  684.8721 (pep-
tide LQEEIDAVLPNK) or m/z 476.7242 (peptide YWTEPEK)) and
an isolation window of 2 m/z. The peptide LQEEIDAVLPNK
(m/z 684.8271) could be detected (Fig. 1a). We  used the same
isolation window for collection and fragmentation of the
ions resulting in the corresponding MS/MS spectrum for the
peptide LQEEIDAVLPNK with most of the y-ions annotated
(Fig. 1b). For the peptide YWTEPEK and the related spiked
heavy peptides (which both incorporate a 13C6, 15N2 isotopi-
cally labeled lysine that causes a mass difference of 8 Da), SIM
scans and MS/MS spectra are given in supporting information
Fig. S-2a–f. All peptides could be veriﬁed by direct infusion-
SIM and were used for further analyses. As these peptides were
e u  p a o p e n p r o t e o m i c s 7 ( 2 0 1 5 ) 20–26 23
Fig. 1 – Peptide veriﬁcation in the direct infusion-SIM setup and correlation of linearity studies. (a) Direct infusion-SIM scan
and (b) corresponding MS/MS  scan for m/z  684.8721 (peptide LQEEIDAVLPNK) and an isolation window of 2 m/z  from
0.2 g/l E. coli membrane fraction containing CYP3A4. The peptide could be detected using the direct infusion-SIM
approach. (c) Ratios of light/heavy peptides determined by direct infusion-SIM and HPLC-SIM and (d) determined by direct
infusion-SIM with the HESI source and the nano source are highly correlated for the peptide LQEEIDAVLPNK and the
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(eptide YWTEPEK. Therefore, direct infusion-SIM is as suita
erely detected in the 2+ charge state, only the corresponding
+ m/z-values were considered for subsequent analyses.
.2.  Calibration  curve
 standard approach for absolute protein quantiﬁcation in
roteomics is to use generated tryptic peptides from the
rotein of interest to quantify the protein amount within
he sample. In order to perform absolute quantiﬁcation of
YP3A4, we  prepared linearity curves for the respective pep-
ides in triplicate and used them for the calculation of absolute
mounts in real samples. For both CYP3A4 peptides we mea-
ured calibration curves in a range from 2 fmol to 2 pmol
supporting information Fig. S-1a and b). Therefore we  used
n E. coli DH5 (pCWori(+)) membrane fraction as matrix in
hat we  spiked varying amounts (2 fmol l−1, 20 fmol l−1,
00 fmol l−1, 500 fmol l−1, 1000 fmol l−1, 2000 fmol l−1) of
ach light CYP3A4 peptide along with a constant amount
f 110 fmol l−1of each heavy peptide. We  analyzed these
amples using direct infusion-SIM as described as well as
PLC-SIM for comparison. With direct infusion-SIM linear-
ty of measurements was achieved and the resulting linear
quation showed a regression coefﬁcient (R2) larger than 0.99
supporting information Fig. S-1a). As expected, also HPLC-SIMor absolute quantiﬁcation as HPLC-SIM.
measurements were linear with an R2 value larger than 0.99
(supporting information Fig. S-1b). Slopes were different for
the different peptides and methods (LQEEIDAVLPNK: 0.0044
(direct infusion-SIM) and 0.0041 (HPLC-SIM), YWTEPEK: 0.0032
(both approaches); supporting information Fig. S-1a and b).
In order to correlate the data for both methods, we  plot-
ted obtained ratios for light and heavy peptides from both
approaches against each other. For both peptides we  observed
high correlation between both approaches with regression
coefﬁcients larger than 0.99 (Fig. 1c).
Precision of both methods was compared for different
amounts of peptides by calculating the coefﬁcient of varia-
tion (CV) (supporting information Tab. S-1). For low amounts
as 2 fmol l−1 CVs were ≥30% with higher CVs for the HPLC-
SIM approach. For amounts of 20 fmol l−1–2000 fmol l−1 the
HPLC-approach showed mainly smaller CVs with <20% for
20 fmol l−1 and <10% for 100 l−1 fmol–2000 fmol l−1 com-
pared to direct infusion-SIM with >15% for 20 and 100 fmol l−1
and <15% for 500 fmol l−1–2000 fmol l−1. This shows that in
the low fmol range both approaches are less precise com-
pared to the high fmol range. Nevertheless, in the high fmol
range also the direct infusion-SIM approach reveals high pre-
cision indicating that it can be used as alternative technique
for HPLC-SIM measurements.
o m i c
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We  successfully demonstrated linearity for direct infusion-
SIM and HPLC-SIM with similar regression coefﬁcients for both
techniques (supporting information Fig. S-1a and b). However,
it was obvious that for direct infusion-SIM, especially signals
from peptides in the low fmol range (2–20 fmol) were less
resolved compared to the high fmol range of 1000–2000 fmol
making data evaluation more  difﬁcult (data not shown). In
HPLC-SIM measurements peptides showed fully resolved sig-
nals in the whole measured range from 2 to 2000 fmol.
Nevertheless, measured ratios of light and heavy peptides cor-
related very well between both techniques showing that direct
infusion-SIM is comparably suitable for absolute quantiﬁca-
tion.
3.3.  Application  of  direct  infusion-SIM  and  HPLC-SIM
to real  samples
After showing a good correlation between the direct infusion-
SIM and HPLC-SIM approach, we  used both methods to
determine absolute amounts of heterologous CYP3A4 sam-
ples derived from E. coli DH5 (pCW3A4). Therefore, we
investigated membrane fractions from nine independent cul-
tivations that were known to express different amounts of
CYP3A4 (unpublished data). In each sample we determined
the ratio of the intensity of light/heavy peptide and after con-
sidering the graph equation of each peptide we  calculated the
absolute amount of light peptide:
fmol Light Peptide = (Intensity Light Peptide/Intensity Heavy 
Slope of Calibration Cu
As expected, the different membrane fractions revealed
varying amounts of CYP3A4. Absolute amounts of CYP3A4
ranged from 34 fmol/0.1 g total protein (±16.81 (s.e.m.; stan-
dard error of the mean) (34 nM)  to 1876 fmol/0.1 g total
protein (±88.78 (s.e.m.)) (1876 nM)  for direct infusion-SIM
and 24 fmol/0.1 g total protein (±0.24 (s.e.m.)) (34 nM) to
1697 fmol/0.1 g total protein (±3.12 (s.e.m.)) (1697 nM)  for
HPLC-SIM (Fig. 2a and b) showing that quantiﬁcation in the
low nM range is achievable also with direct infusion-SIM.
The use of the two peptides with direct-infusion SIM
resulted in higher error bars for the determined amounts of
CYP3A4 compared to HPLC-SIM (Fig. 2a and b). Whereas we
used spiked light CYP3A4 peptides for creating the calibration
curve, in samples expressing CYP3A4 the endogenous/light
Fig. 2 – Comparison of quantiﬁcation results in real samples. (a) 
membranes derived from nine independent cultivation experime
HPLC-SIM. Calculated amounts for both peptides were  averaged  s 7 ( 2 0 1 5 ) 20–26
ide) − y Intercept
peptides were released upon digestion. Hence, the diverging
results for the two peptides may result from incomplete diges-
tion or different peptide decay during digestion [20]. The fact
that the HPLC measurements were more  consistent for the
two peptides might be due to a more  accurate measurement
caused by a peptide pre-separation and therefore less dis-
turbing/suppressing co-measured ions in the SIM. Especially,
the peptide YWTEPEK with an m/z of 476.7242 was always
accompanied by an m/z of 476.7638 in the direct infusion-
SIM approach (supporting information Fig. S-2a), that was of
course not detected in the HPLC-SIM approach. Even though
the calculated amounts for CYP3A4 were slightly different for
the two methods, amounts obtained with direct infusion-SIM
only deviated on average of 14.7% (±4.1 (s.e.m.)) from data
obtained with HPLC-SIM. This is a small variance regarding
that the comparison of HPLC-SRM and HPLC-SIM for the quan-
tiﬁcation of transferrin in urine samples revealed less than
10% difference between the approaches [8]. Furthermore, com-
parison of LC-MRM and direct infusion-MRM of heat shock
proteins showed errors of up to >30% [21]. With the direct
infusion-SIM approach absolute quantiﬁcation is even more
robust due to an averaged error of <15%. Moreover, SIM mea-
surements are simpler than MRM measurements because no
optimization of transitions is needed. Another advantage of
direct infusion-SIM over direct infusion-MRM is that no cor-
rection factor for quantiﬁcation is needed.
3.4.  Data  evaluation  for  shortened  analysis  time
After showing that direct infusion-SIM and HPLC-SIM revealed
similar absolute amounts of CYP3A4, data evaluation for the
direct infusion-SIM approach was performed for only 30 s
of the analyzed time and compared to HPLC-SIM results in
order to show that analysis time could be further decreased.
In this case, absolute amounts of the CYP3A4 within 100 ng
of total protein sample ranged from 36 fmol (±14.02 (s.e.m.))
to 1926 fmol (±303.84 (s.e.m.)) corresponding to 36–1926 nM
CYP3A4 (supporting information Fig. S-3). Using the 30 s anal-
ysis time revealed only a variance of 16.7% ((±4.0 (s.e.m.))
compared to HPLC-SIM, conﬁrming that analysis time can be
Absolute quantiﬁcation of CYP3A4 in E. coli DH5 (pCW3A4)
nts (1–9) was performed with direct infusion-SIM and (b)
and showed similar results for both approaches.
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urther decreased. Provided that spray stability is high analysis
imes of 30 s are sufﬁcient to gain similar results as compared
o 4.5 min  analysis time with only a slight increase in the vari-
nce between direct infusion-SIM and HPLC-SIM.
.5.  Comparison  of  HESI-direct  infusion  vs.
ano-direct  infusion
ue to the extremely short measuring time with direct
nfusion-SIM of 4.5 min  or even 30 s per sample compared
o 65 min  for nano HPLC-SIM, sample throughput is much
igher and allows fast comparison of samples. Besides this
dvantage, a remaining drawback of direct infusion-SIM exists
ith respect to sample consumption. Relatively high sam-
le amounts are needed to prepare the samples for the
njection via a syringe pump and HESI source. Whereas in
irect infusion-SIM we  measured sample concentrations of
.1 g l−1 with a ﬂow rate of 5 l min−1, for HPLC-SIM mea-
urements 0.1 g sample on column is sufﬁcient. In order to
educe the required sample amount a nano source application
as used for direct infusion-SIM. First measurements showed
romising results so that for future applications sample vol-
me  will only be a few microliter (1–10 l). With the nano direct
nfusion-SIM setup a further linearity study was performed.
btained data (ratios for light and heavy peptides from both
pproaches, HESI direct infusion-SIM vs. nano direct infusion-
IM) were plotted against each other in order to correlate the
ata for either method. For both peptides we observed high
orrelation between the two approaches with R2 values larger
han 0.99 (Fig. 1d). These ﬁrst measurements already revealed
omparable results for direct infusion with the HESI source or
ano source. In addition, the use of the nano static spray will
ring further advantages regarding the accuracy of the mea-
urements. With this, the lower signal-to-noise ratios in direct
nfusion-SIM compared to HPLC-SIM will partly be overcome.
igher signal to noise ratios lead to better resolved SIM signals
n direct infusion-SIM for the values between 2 and 20 fmol
data not shown).
.  Conclusion
t was shown that direct infusion-SIM can be used as an alter-
ative method for absolute quantiﬁcation, also in complex
iological samples. This method allows a reproducible (similar
o that of HPLC-SIM) quantiﬁcation as shown here for human
YP3A4 in E. coli membrane fractions down to an amount of
4 fmol/0.1 g protein (34 nM). When using this method some
equisites need to be fulﬁlled: (1) quantiﬁed peptides need to
ave unique masses within the sample, (2) quantiﬁed pep-
ides should be present in the lower nM range or higher and
3) sample amounts of 1 g should be available.
The successful application of direct infusion-SIM for abso-
ute quantiﬁcation of proteins in complex samples consisting
f microbial membranes as shown in this study might in
uture also be used for quantiﬁcation of abundant and/or pre-
nriched proteins in complex samples from different origin.
urthermore, it can also be used for a fast relative quantiﬁca-
ion, e.g. to determine the inﬂuence of different expression
onditions on several proteins within one sample. Another 7 ( 2 0 1 5 ) 20–26 25
advantage of direct infusion-SIM over HPLC-based methods
is that when it comes to peptide selection for targeted pro-
tein quantiﬁcation, also highly hydrophilic and hydrophobic,
or rather long peptides (30–50 amino acids), that usually are
not analyzable using conventional C18-reversed phase HPLC,
can be detected with the direct infusion approach and thus
be used for protein quantiﬁcation by direct infusion-SIM. First
results for this application of direct infusion-SIM have shown
to be promising (unpublished data). However, to achieve more
accurate results peptides should be selected with m/z  values
that are not too close to m/z values from other peptides in the
sample, as was discussed for the peptide YWTEPEK. A ﬁnal
advantage of direct infusion-SIM over HPLC-SIM is the fact
that resolution can be easily increased without losing acqui-
sition of data points (although it was not done in this study in
order to keep analysis parameters comparable for HPLC and
direct infusion). Scanning with higher resolution is associ-
ated with longer scanning times. In HPLC-SIM measurements
peptides elute for a certain time in that they are alternately
collected and scanned. Longer scanning times increase the
cycle time so that less data points will be acquired over the
elution peak which makes data evaluation less accurate, espe-
cially for low abundant proteins. In direct infusion-SIM all
peptides are injected throughout the whole acquisition time.
Therefore, longer cycle times due to increased resolution can
be compensated by longer acquisition times.
Altogether, we  here demonstrate the potential of a fast,
easy (no need for optimization of analysis parameters or
data evaluation), robust and reproducible direct infusion-SIM
approach and its applicability in protein/peptide quantiﬁca-
tion in complex samples with promising efﬁciency for future
biological as well as clinical applications.
Transparency  document
The Transparency document associated with this article can
be found in the online version.
Acknowledgements
Support by the Deutsche Forschungsgemeinschaft (DFG),
project “Untersuchung und Optimierung von CYP450-expri-
mierenden Mikroorganismen für Wirkstoffderivatisierungss-
tudien und Produktion von Wirkstoffmetaboliten” (MA
3257/3-1), the Bundesministerium für Bildung und
Forschung/EU (BMBF/EU), project “JPND Verbundprojekt
BIOMARKAPD, Etablierung von SRM-Analysen für die
Biomarker Analytik von Alzheimer und Parkinson relevanten
Proteinen” (01ED1203G), Protein Unit for Research in Europe
(P.U.R.E.), a project of North Rhine-Westphalia (Germany),
and FoRUM (Forschungsförderung Ruhr-Universität Bochum
Medizinische Fakultät; F800-2014) are gratefully acknowl-
edged.
Appendix  A.  Supplementary  dataSupplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.euprot.2015.03.001.
o m i c
r
(PC-IDMS). Mol Cell Proteomics 2012;11:814–23.
[21] Xiang Y, Koomen JM. Evaluation of direct infusion-multiple26  e u  p a o p e n p r o t e 
 e  f  e  r  e  n  c  e  s
[1] Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP.
Absolute quantiﬁcation of proteins and phosphoproteins
from cell lysates by tandem MS. Proc Natl Acad Sci U S A
2003;100:6940–5.
[2] Anderson L, Hunter CL. Quantitative mass spectrometric
multiple reaction monitoring assays for major plasma
proteins. Mol Cell Proteomics 2006;5:573–88.
[3] Stahl-Zeng J, Lange V, Ossola R, Eckhardt K, Krek W,
Aebersold R, et al. High sensitivity detection of plasma
proteins by multiple reaction monitoring of N-glycosites.
Mol Cell Proteomics 2007;6:1809–17.
[4] Lange V, Malmström JA, Didion J, King NL, Johansson BP,
Schäfer J, et al. Targeted quantitative analysis of
Streptococcus pyogenes virulence factors by multiple reaction
monitoring. Mol Cell Proteomics 2008;7:1489–500.
[5] Sano S, Tagami S, Hashimoto Y, Yoshizawa-Kumagaye K,
Tsunemi M, Okochi M, et al. Absolute quantitation of low
abundance plasma APL1  ˇ peptides at sub-fmol/mL level by
SRM/MRM without immunoafﬁnity enrichment. J Proteome
Res  2014;13(2):1012–20.
[6] Langenfeld E, Zanger UM, Jung K, Meyer HE, Marcus K. Mass
spectrometry-based absolute quantiﬁcation of microsomal
cytochrome P450 2D6 in human liver. Proteomics
2009;9:2313–23.
[7] Michalski A, Damoc E, Hauschild J-P, Lange O, Wieghaus A,
Makarov A, et al. Mass spectrometry-based proteomics
using Q Exactive, a high-performance benchtop quadrupole
Orbitrap mass spectrometer. Mol Cell Proteomics 2011;10.
M111.011015.
[8] Gallien S, Duriez E, Crone C, Kellmann M, Moehring T,
Domon B. Targeted proteomic quantiﬁcation on
quadrupole-orbitrap mass spectrometer. Mol Cell
Proteomics 2012;11:1709–23.[9] Maerkens A, Kley RA, Olivé M, Theis V, van der Ven PFM,
Reimann J, et al. Differential proteomic analysis of abnormal
intramyoplasmic aggregates in desminopathy. J Proteomics
2013;90:14–27. s 7 ( 2 0 1 5 ) 20–26
[10] Li F, Qin X, Chen H, Qiu L, Guo Y, Liu H, et al. Lipid proﬁling
for  early diagnosis and progression of colorectal cancer
using direct-infusion electrospray ionization Fourier
transform ion cyclotron resonance mass spectrometry.
Rapid Commun Mass Spectrom 2013;27:24–34.
[11] Shi X, Wahlang B, Wei X, Yin X, Falkner KC, Prough RA, et al.
Metabolomic analysis of the effects of polychlorinated
biphenyls in nonalcoholic fatty liver disease. J Proteome Res
2012;11:3805–15.
[12] Guengerich FP. Reactions and signiﬁcance of cytochrome
P-450 enzymes. J Biol Chem 1991;266:10019–22.
[13] Hasler JA, Estabrook R, Murray M,  Pikuleva I, Waterman M,
Capdevila J, et al. Human cytochromes P450. Mol Aspects
Med 1999;20:1–137.
[14] Julsing MK, Cornelissen S, Bühler B, Schmid A. Heme-iron
oxygenases: powerful industrial biocatalysts? Curr Opin
Chem Biol 2008;12:177–86.
[15] Hanahan D. Studies on transformation of Escherichia coli with
plasmids. J Mol Biol 1983;166:557–80.
[16] Parikh A, Gillam EM, Guengerich FP. Drug metabolism by
Escherichia coli expressing human cytochromes P450. Nat
Biotechnol 1997;15:784–8.
[17] Sambrook J, Russell D, editors. Molecular cloning—a
laboratory manual. Cold Spring Harbor, New York, USA: Cold
Spring Harbor Laboratory Press; 2001.
[18] Gillam EM, Baba T, Kim BR, Ohmori S, Guengerich FP.
Expression of modiﬁed human cytochrome P450 3A4 in
Escherichia coli and puriﬁcation and reconstitution of the
enzyme. Arch Biochem Biophys 1993;305:123–31.
[19] Lange V, Picotti P, Domon B, Aebersold R. Selected reaction
monitoring for quantitative proteomics: a tutorial. Mol Syst
Biol  2008;4:222.
[20] Shuford CM, Sederoff RR, Chiang VL, Muddiman DC. Peptide
production and decay rates affect the quantitative accuracy
of  protein cleavage isotope dilution mass spectrometryreaction monitoring mass spectrometry for quantiﬁcation of
heat shock proteins. Anal Chem 2012;84:1981–6.
